Marina Faedi
Ospedale San Carlo(IT)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Cancer Treatment and Pharmacology, Epigenetics and DNA Methylation, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial(2018)372 cited
- → Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life(2016)185 cited
- → Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial(2016)170 cited
- → Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors(2013)106 cited
- → Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)(2009)100 cited
- → Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma(2015)67 cited
- → Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma(2016)66 cited
- → The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power(2018)58 cited
- → Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology)(2015)44 cited
- → Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016(2019)40 cited